Home > Financial Ratios > SHUKRA PHARMACEUTICALS

SHUKRA PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
SHUKRA PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SHUKRA PHARMACEUTICALS
Please provide your vote to see the results

SHUKRA PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -23.77238.70121.1264.8116.13

What is the latest Core EBITDA Growth ratio of SHUKRA PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of SHUKRA PHARMACEUTICALS is -23.77 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-23.77
Mar2024238.70
Mar2023121.12
Mar202264.81
Mar202116.13

How is Core EBITDA Growth of SHUKRA PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 -23.77
Negative
Mar2024 238.7
97.08
Mar2023 121.12
86.88
Mar2022 64.81
301.80
Mar2021 16.13 -

Other Financial Ratios of SHUKRA PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of SHUKRA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SHUKRA PHARMACEUTICALS ₹1,428.4 Cr -6.5% -13% 66% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹388,680.0 Cr -2.9% -8.9% -3.7% Stock Analytics
DIVIS LABORATORIES ₹168,817.0 Cr 1.2% 4.2% 8.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹139,297.0 Cr -1.7% -3.6% 27.4% Stock Analytics
DR REDDYS LABORATORIES ₹109,828.0 Cr 6.8% 1.3% 13.2% Stock Analytics
CIPLA ₹104,588.0 Cr 5.4% 3.1% -13.6% Stock Analytics


SHUKRA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SHUKRA PHARMACEUTICALS

-6.5%

-13%

66%

SENSEX

-2.3%

3.3%

-2.4%


You may also like the below Video Courses